Bulletin
Investor Alert

New York Markets After Hours

Company Close Updates

Dec. 1, 2021, 4:31 p.m. EST

Moderna Inc. stock underperforms Wednesday when compared to competitors

MarketWatch Automation

Shares of Moderna Inc. (NAS:MRNA) took a -12% dive 11.87% to $310.61 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index (NASDAQ:COMP) falling 1.83% to 15,254.05 and Dow Jones Industrial Average (DOW:DJIA) falling 1.34% to 34,022.04. This was the stock's second consecutive day of losses. Moderna Inc. closed $186.88 short of its 52-week high ($497.49), which the company reached on August 10th.

The stock underperformed when compared to some of its competitors Wednesday, as AbbVie Inc. (NYS:ABBV) rose 0.55% to $115.91, Amgen Inc. (NAS:AMGN) rose 0.97% to $200.80, and AstraZeneca PLC ADR (NAS:AZN) rose 0.09% to $54.88. Trading volume (21.3 M) eclipsed its 50-day average volume of 13.1 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Link to MarketWatch's Slice.